Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study

OBJECTIVE: To assess the eligibility of patients participating in DISCOVER (a 3-year, prospective, observational study program of 15 992 patients with type 2 diabetes [T2D] initiating a second-line glucose-lowering therapy across 38 countries) for four cardiovascular outcomes trials (CVOTs) of sodiu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pintat, Stéphane, Fenici, Peter, Hammar, Niklas, Ji, Linong, Khunti, Kamlesh, Medina, Jesús, Tang, Fengming, Wittbrodt, Eric, Surmont, Filip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501855/
https://www.ncbi.nlm.nih.gov/pubmed/31114700
http://dx.doi.org/10.1136/bmjdrc-2018-000627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501855/
https://www.ncbi.nlm.nih.gov/pubmed/31114700
http://dx.doi.org/10.1136/bmjdrc-2018-000627

Ejemplares similares